Composition, form of production and packaging
? Gel for application to the skin 1% semitransparent, with a grayish tint and a specific odor.
1 g 1 tube
dry extract of kelp 10 mg 30 mg
Excipients: polyethylene glycol (up to 3 g).
3 g - tubes (1) complete with adhesive plaster (20 pcs.) - packs of cardboard.
? Gel for application to the skin 1% semitransparent, with a grayish tint and a specific odor.
1 g 1 tube
dry extract of kelp 10 mg 50 mg
Excipients: polyethylene glycol (up to 5 g).
5 g - tubes (1) complete with adhesive plaster (35 pcs.) - packs of cardboard.
? Gel for application to the skin 1% semitransparent, with a grayish tint and a specific odor.
1 g 1 tube
dry extract of kelp 10 mg 100 mg
Excipients: polyethylene glycol (up to 10 g).
10 g - tubes (1) complete with adhesive plaster (70 pcs.) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2005.
PHARMACHOLOGIC EFFECT
The drug for use in ophthalmology. Extract of seaweed kelp, which is part of Okovidit, contains a complex of amino acids, macro and microelements, vitamins, organically bound iodine. The drug improves metabolism and circulation in the eye tissues, has a reparative and absorbable effect, promotes resorption of opacities and faster healing of damage to the cornea of ​​various origins, reduces dystrophic processes, improves visual functions.
Transdermal application of Okovid provides a longer lasting effect of the biologically active substances that make up the preparation.
INDICATIONS
- Dystrophic diseases of the anterior part of the eye (corneal dystrophy, conjunctiva);
- Postoperative pain syndrome;
- to accelerate the processes of corneal regeneration after surgery and trauma;
- opacity of the cornea of ​​various origins (consequences of viral keratitis, bacterial ulcers, trauma and eye burns);
- damage to the cornea when using contact lenses;
- central chorioretinal degeneration of the retina (dry form).
DOSING MODE
The tissue base of the attached adhesive plaster is applied, evenly distributing, a strip of gel 7-8 mm in length. Adhesive tape adhered to the skin of the lower eyelid, receding 2 mm from the ciliary edge, for 1-3 hours daily. The duration of exposure to the drug can be increased to 8-10 hours (for example, with the drug before bedtime). It is allowed to apply the gel directly to the skin of the lower or upper eyelid without the use of adhesive plaster. The course of treatment is 10 days. If necessary, treatment can be extended up to 30 days. It is possible to conduct repeated courses of treatment.
Application rules
1. Remove the protective coating of adhesive plaster. If desired, you can reduce the fixing surface. In this case, before removing the protective cover, cut off 5-7 mm of adhesive plaster on each side.
2. Press the gel onto the absorbent fabric pad.
3. Stick adhesive plaster on the skin of the lower eyelid (receding 2 mm from the ciliary edge). After the treatment procedure, it is more convenient to peel off the patch by the middle.
SIDE EFFECT
Local reactions: irritation of the skin of the eyelids at the place of application of the adhesive plaster (in this case it is possible to apply the gel to the skin of the lower or upper eyelid without the use of adhesive plaster).
CONTRAINDICATIONS
- dermatitis in the eyelid;
- Eversion of the eyelids;
- Acute adenoviral and bacterial conjunctivitis;
- allergic reactions to iodine preparations;
- increased individual sensitivity to kelp or other components of the drug.
PREGNANCY AND LACTATION
It is possible to use Okovid in pregnancy and lactation (breastfeeding).
SPECIAL INSTRUCTIONS
The drug is intended only for transdermal use.
OVERDOSE
Cases of overdose of the drug Okovidit are not described.
DRUG INTERACTION
Data on the incompatibility of the drug Okovidit with other drugs do not.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a place protected from light, inaccessible to children, at a temperature of no higher than 10 В° C; Do not freeze! Shelf life - 2 years.
After opening the tube, the drug should be used within 30 days.
Conditions of leave from pharmacies
The drug is approved for use as a means of OTC.
